Susquehanna International Group, LLP Purple Biotech Ltd. Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.39 - $4.15 $31,395 - $54,514
-13,136 Reduced 53.62%
11,361 $27,000
Q1 2022

May 16, 2022
SELL
$2.45 - $4.3 $24,078 - $42,260
-9,828 Reduced 28.63%
24,497 $97,000
Q4 2021

Feb 14, 2022
BUY
$3.75 - $4.67 $51,172 - $63,726
13,646 Added 65.99%
34,325 $134,000
Q4 2020

Feb 16, 2021
BUY
$3.81 - $4.73 $78,786 - $97,811
20,679 New
20,679 $79,000

Others Institutions Holding PPBT

# of Institutions
1
Shares Held
15
Call Options Held
0
Put Options Held
0
View Full List

About PURPLE BIOTECH LTD.

PPBT Quotes by TradingView
  • Ticker PPBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,303,300
  • Market Cap $67M
  • Description
  • Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...
More about PPBT
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email